JP2022543598A5 - - Google Patents
Info
- Publication number
- JP2022543598A5 JP2022543598A5 JP2022506697A JP2022506697A JP2022543598A5 JP 2022543598 A5 JP2022543598 A5 JP 2022543598A5 JP 2022506697 A JP2022506697 A JP 2022506697A JP 2022506697 A JP2022506697 A JP 2022506697A JP 2022543598 A5 JP2022543598 A5 JP 2022543598A5
- Authority
- JP
- Japan
- Prior art keywords
- pain
- nle
- tic
- seq
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962881725P | 2019-08-01 | 2019-08-01 | |
| US62/881,725 | 2019-08-01 | ||
| PCT/US2020/044045 WO2021021915A1 (en) | 2019-08-01 | 2020-07-29 | Compositions comprising chemerin analogs and methods of use |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022543598A JP2022543598A (ja) | 2022-10-13 |
| JP2022543598A5 true JP2022543598A5 (https=) | 2023-08-07 |
| JP7651553B2 JP7651553B2 (ja) | 2025-03-26 |
Family
ID=72087242
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506697A Active JP7651553B2 (ja) | 2019-08-01 | 2020-07-29 | ケメリン類似体を含む組成物とその使用方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US12559523B2 (https=) |
| EP (2) | EP4007635B1 (https=) |
| JP (1) | JP7651553B2 (https=) |
| AU (1) | AU2020321898B2 (https=) |
| CA (1) | CA3149397A1 (https=) |
| WO (1) | WO2021021915A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4522118A2 (en) * | 2022-05-12 | 2025-03-19 | Okyo Pharma Limited | Chemerin-containing formulation for treating dry eye disease |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7419658B2 (en) * | 2001-07-09 | 2008-09-02 | Euroscreen S.A. | Isolated ligand of ChemerinR |
| US20090053831A1 (en) * | 2007-05-01 | 2009-02-26 | Cell Signaling Technology, Inc. | Tyrosine phosphorylation sites |
| JP2010229093A (ja) | 2009-03-27 | 2010-10-14 | Banyu Pharmaceut Co Ltd | 新規ＣｈｅｍｅｒｉｎＲアゴニスト |
| US20170039314A1 (en) * | 2010-03-23 | 2017-02-09 | Iogenetics, Llc | Bioinformatic processes for determination of peptide binding |
| WO2013117581A1 (en) | 2012-02-10 | 2013-08-15 | Charite - Universitätsmedizin Berlin | Metabolically stable variants of chemerin 9 |
| WO2014168721A2 (en) * | 2013-04-12 | 2014-10-16 | Tufts Medical Center | Methods and systems for designing and/or characterizing soluble lipidated ligand agents |
| EP3405208B1 (en) * | 2016-01-22 | 2020-04-29 | Tufts Medical Center, Inc. | Compounds and methods for treating inflammation |
| TWI796339B (zh) * | 2017-06-27 | 2023-03-21 | 大陸商尚華醫藥科技（江西）有限公司 | 一種肽類化合物、其應用及含其的組合物 |
-
2020
- 2020-07-29 US US17/631,032 patent/US12559523B2/en active Active
- 2020-07-29 WO PCT/US2020/044045 patent/WO2021021915A1/en not_active Ceased
- 2020-07-29 AU AU2020321898A patent/AU2020321898B2/en active Active
- 2020-07-29 EP EP20757112.6A patent/EP4007635B1/en active Active
- 2020-07-29 JP JP2022506697A patent/JP7651553B2/ja active Active
- 2020-07-29 EP EP22211483.7A patent/EP4218927A3/en active Pending
- 2020-07-29 CA CA3149397A patent/CA3149397A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023002662A5 (https=) | ||
| AU2018357775B2 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| JP6837486B2 (ja) | 加齢に関連する認知障害及び神経炎症を予防及び／又は治療する方法 | |
| JP2015526458A5 (https=) | ||
| JP2018507243A5 (https=) | ||
| EA201270144A1 (ru) | Комбинированная терапия при лечении диабета | |
| ES2704229T3 (es) | Agonistas selectivos del receptor AT2 para su uso en el tratamiento de la caquexia | |
| IL265761B2 (en) | Oral terlipressin compositions for use in treatment of ascites | |
| JP2023500032A5 (https=) | ||
| EP4520394A3 (en) | New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases | |
| JP2022523530A5 (https=) | ||
| WO2009003694A3 (en) | Method for treating diseases related to mitochondrial dysfunction | |
| CN107137417B (zh) | 一种用于治疗恶病质的药物组合物及其应用 | |
| WO2009123206A1 (ja) | 経口医薬組成物 | |
| JP2016505050A5 (https=) | ||
| US10258632B2 (en) | Method of prevention of neurological diseases | |
| JP2019507786A5 (https=) | ||
| JP2022543598A5 (https=) | ||
| US20210393549A1 (en) | New use of R-enantiomer of adrenergic beta 2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations | |
| US20210137905A1 (en) | 1-piperidinepropionic acid for treating a fibrosing disease | |
| CN114288289A (zh) | 具有镇痛和/或止痒功能的药物组合物及其应用 | |
| CN105497019A (zh) | 胺类化合物治疗疼痛的医药用途 | |
| JP2023531930A5 (https=) | ||
| JP2023523247A (ja) | ウイルス感染症の治療のためのレニン－アンジオテンシン系（ｒａｓ）モジュレーター、それを含む医薬組成物、およびそれを用いた治療方法 | |
| JP7644988B2 (ja) | Ｈｄａｃ阻害剤と抗ｐｄ－１抗体または抗ｐｄ－ｌ１抗体とを含む薬学組成物 |